Speaker(s): 

Jason L. Vassy, MD, MPH, MS- Director, Genomes2Veterans Research Program, VA Boston Healthcare System, Associate Professor of Medicine, Harvard Medical School, has nothing to disclose.
 
Morgan Danowski, MS, CGC- Genetic Counselor and Project Manager, Genomes2Veterans Research Program, VA Boston Healthcare System, discloses the following: Arboretum LifeSciences-Consultant/Advisor.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 
  1. Describe the design and scope of the ProGRESS and MVP-ROAR studies
  2. Discuss the impact of genomic screening on veteran health outcomes and risk assessment
  3. Assess current barriers and facilitators for broad implementation of genomic screening in the VA

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Juliann Savatt, MS, LCGC, Melissa Kelly, MS, LCGC, Marc Williams, MD, and Cara McCormick, MPH have no identified disclosures. 
 
CE Committee Member/Content Reviewers have nothing to disclose: Christen Mowad, MD, Alison Mowery, DNP, CRNP
 
Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session:

None
Session date: 
07/13/2026 - 12:00pm to 1:00pm EDT
Location: 
Virtual via Microsoft Teams
Danville, PA 17822
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation Credit
Please login or register to take this course.